HMGB1 and cancer: Recently, the unique ability of doxorubicin, daunorubicin and mitoxantrone to make cancer cells immunogenic was shown to be through calreticulin re-localization to the cell surface [10] and the selective induction and release of High-mobility group box 1 (HMGB1) protein from dying cancer cells [11].